Current stock page

Financial Data

PRAX Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

PRAXPraxis Precision Medicines, Inc.

Healthcare / Biotechnology

Relative Leader / Watch

Strong Relative Position

NeutralEdge 9/10
$328.13+$3.37 (+1.04%)

Latest quote

  • Momentum
    48
  • Value
    —
  • Quality
    72
  • Risk resilience
    47
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$0$0$0$0$0$0$0$7.46M
Gross Profit$0$0-$39K-$77.51M-$65.8M-$63.01M-$60.81M-$48.83M
Operating Income-$106.91M-$96.9M-$105.86M-$97.04M-$78.36M-$76.07M-$74.73M-$63.96M
Net Income-$94.23M-$83.72M-$92.56M-$88.91M-$73.93M-$71.13M-$69.3M-$58.68M
EPS-$3.23-$2.87-$3.2-$3.52-$3.36-$3.31-$3.29-$2.94
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow-$81.74M-$77.64M-$86.05M-$77.26M-$64.74M-$54.68M-$52.71M-$56.12M
Capital Expenditure-$779K-$245K-$62K$0$0-$120K$0$0
Free Cash Flow-$82.52M-$77.89M-$86.11M-$77.26M-$64.74M-$54.8M-$52.71M-$56.12M
Net Cash Provided By Operating Activities-$81.74M-$77.64M-$86.05M-$77.26M-$64.74M-$54.68M-$52.71M-$56.12M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$1.31B$1.39B$1.46B$937.91M$396.39M$452.83M$478.74M$483.11M
Total Debt$732K$1.09M$1.44M$110K$436K$755K$1.07M$1.37M
Cash And Cash Equivalents$361.85M$474.76M$536.33M$357.33M$149.53M$157.42M$165.57M$215.37M
Total Liabilities$52.5M$49.06M$50.24M$59.77M$52.88M$48.61M$39.52M$37.66M
Total Stockholders Equity$1.26B$1.34B$1.41B$878.14M$343.51M$404.22M$439.21M$445.45M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio7.718.046.838.510.532.711.931.73
P/S ratio————————
Debt To Equity00000000
Free Cash Flow Yield-3.33%-2.84%-2.94%-3.34%-6.31%-17.42%-19.31%-17.05%
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio7.718.046.838.510.532.711.931.73
P/S ratio————————
Return On Equity-28.54%-25.29%-23.16%-34.54%-79.49%-62.10%-48.40%-41.04%
Debt To Equity00000000

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe-25.6x
Pb7.6x
EPS Growth Yoy3.87%
Gross Margin0.00%
Operating Margin0.00%
ROE-29.41%
ROIC-32.27%
Debt To Equity0
FCF Yield-3.53%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$328.13
Volume352,886
RSI (14)61.44
MACD13.06
MACD signal5.11
MACD histogram7.96
ADX (14)23.45
SMA (50)$289.90
SMA (200)$314.58
ATR (14)$17.96
Historical volatility (annualized)93.73%
Volume (20-day average)490,325

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score47/100
Beta1.58
Annual volatility75.11%
Max Drawdown-38.13%
Sharpe Ratio1.13
VaR (95%, 1-day)-5.47%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

PRAX Financial Data FAQ

What is Praxis Precision Medicines, Inc.'s revenue?

Praxis Precision Medicines, Inc.'s revenue is one of the core financial data points for PRAX. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Praxis Precision Medicines, Inc.'s revenue growing?

Revenue growth shows whether Praxis Precision Medicines, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is PRAX's EPS?

PRAX's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Praxis Precision Medicines, Inc.'s net income?

Praxis Precision Medicines, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Praxis Precision Medicines, Inc. generate?

Free cash flow shows how much cash Praxis Precision Medicines, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Praxis Precision Medicines, Inc. have?

Cash and debt help frame PRAX's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.